PE20090141A1 - Compuestos derivados de isoquinolina proceso de preparacion y composicion farmaceutica - Google Patents

Compuestos derivados de isoquinolina proceso de preparacion y composicion farmaceutica

Info

Publication number
PE20090141A1
PE20090141A1 PE2008000613A PE2008000613A PE20090141A1 PE 20090141 A1 PE20090141 A1 PE 20090141A1 PE 2008000613 A PE2008000613 A PE 2008000613A PE 2008000613 A PE2008000613 A PE 2008000613A PE 20090141 A1 PE20090141 A1 PE 20090141A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxy
halo
compounds derived
pharmaceutical composition
Prior art date
Application number
PE2008000613A
Other languages
English (en)
Spanish (es)
Inventor
Matthew Hallam
Barrie Martin
Piotr Raubo
Bryan Roberts
Stephen St-Gallay
Paul Willis
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20090141A1 publication Critical patent/PE20090141A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PE2008000613A 2007-04-05 2008-04-04 Compuestos derivados de isoquinolina proceso de preparacion y composicion farmaceutica PE20090141A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91023507P 2007-04-05 2007-04-05
US97952307P 2007-10-12 2007-10-12

Publications (1)

Publication Number Publication Date
PE20090141A1 true PE20090141A1 (es) 2009-04-30

Family

ID=39560895

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000613A PE20090141A1 (es) 2007-04-05 2008-04-04 Compuestos derivados de isoquinolina proceso de preparacion y composicion farmaceutica

Country Status (19)

Country Link
US (1) US8012979B2 (ru)
EP (1) EP2144881B1 (ru)
JP (1) JP5400759B2 (ru)
KR (1) KR20100016218A (ru)
CN (1) CN101679275B (ru)
AR (1) AR065965A1 (ru)
AU (1) AU2008235359B2 (ru)
BR (1) BRPI0810047A2 (ru)
CA (1) CA2681221A1 (ru)
CL (1) CL2008000973A1 (ru)
CO (1) CO6230983A2 (ru)
EC (1) ECSP099679A (ru)
IL (1) IL201015A0 (ru)
MX (1) MX2009010225A (ru)
PE (1) PE20090141A1 (ru)
RU (1) RU2472781C2 (ru)
TW (1) TW200845988A (ru)
UY (1) UY31005A1 (ru)
WO (1) WO2008122765A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR073711A1 (es) * 2008-10-01 2010-11-24 Astrazeneca Ab Derivados de isoquinolina
AR092742A1 (es) * 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN103864684A (zh) * 2012-12-07 2014-06-18 天津科技大学 一种新颖的3,4-二氢-1(2h)异喹啉类衍生物的合成与抗肿瘤药物的应用
CA2927830A1 (en) 2013-10-23 2015-04-30 Chugai Seiyaku Kabushiki Kaisha Quinazolinone and isoquinolinone derivative
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106674254B (zh) * 2016-12-21 2019-03-15 广东省中医院 一类喹诺酮羧酸化合物及其中间体、制备方法以及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176214B (en) * 1977-05-18 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 5,6-dihydro-imidazo-square bracket-5,1-a-square bracket closed-isoquinolin derivatives
JP4619545B2 (ja) 1999-03-17 2011-01-26 アストラゼネカ アクチボラグ アミド誘導体
AU2003211931A1 (en) * 2002-02-13 2003-09-04 Takeda Chemical Industries, Ltd. Jnk inhibitor
ATE420847T1 (de) * 2002-02-21 2009-01-15 Asahi Kasei Pharma Corp Substituiertes phenylalkansäurederivat und dessen verwendung
US6867320B2 (en) * 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
KR101175371B1 (ko) 2003-08-06 2012-08-20 바스프 에스이 하나 이상의 유기 화합물의 연속 불균일 촉매적 기체상부분 산화 수행 방법
CA2535665A1 (en) 2003-08-14 2005-02-24 Asahi Kasei Pharma Corporation Substituted arylalkanoic acid derivative and use thereof
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
US20070054916A1 (en) * 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
BRPI0519287A2 (pt) 2004-12-24 2009-01-06 Astrazeneca Ab derivados de amida
TW200728277A (en) * 2005-06-29 2007-08-01 Palau Pharma Sa Bicyclic derivatives as P38 inhibitors
BRPI0614063A2 (pt) 2005-07-26 2011-03-09 Sanofi Aventis derivados de cicloexilamina isoquinolona

Also Published As

Publication number Publication date
JP5400759B2 (ja) 2014-01-29
JP2010523533A (ja) 2010-07-15
KR20100016218A (ko) 2010-02-12
CN101679275A (zh) 2010-03-24
UY31005A1 (es) 2008-11-28
WO2008122765A1 (en) 2008-10-16
AR065965A1 (es) 2009-07-15
AU2008235359A1 (en) 2008-10-16
CN101679275B (zh) 2013-07-31
MX2009010225A (es) 2009-12-14
RU2472781C2 (ru) 2013-01-20
EP2144881A1 (en) 2010-01-20
IL201015A0 (en) 2010-05-17
ECSP099679A (es) 2009-11-30
AU2008235359B2 (en) 2011-12-15
CO6230983A2 (es) 2010-12-20
EP2144881B1 (en) 2012-06-20
CA2681221A1 (en) 2008-10-16
CL2008000973A1 (es) 2009-01-02
US8012979B2 (en) 2011-09-06
RU2009136246A (ru) 2011-05-10
BRPI0810047A2 (pt) 2014-10-21
US20090023746A1 (en) 2009-01-22
TW200845988A (en) 2008-12-01

Similar Documents

Publication Publication Date Title
DE602005008558D1 (de) Kondensierte heterocyclische verbindungen und deren verwendung als antagonisten des metabotropen reznkungen
PE20090141A1 (es) Compuestos derivados de isoquinolina proceso de preparacion y composicion farmaceutica
EA200601266A1 (ru) Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
CY1110952T1 (el) Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3
BG108650A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
TW200635585A (en) Monocyclic substituted methanones
ATE464304T1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonist n
PE20140609A1 (es) Diazacarbazoles y metodos de uso
PE20080768A1 (es) Compuestos de isoindolina 5-sustituidos
ATE440834T1 (de) Substituierte arylaminderivate und verwendungsverfahren
MX2011011764A (es) Compuestos de carboxamida y su uso como inhibidores de calpaina.
ATE427932T1 (de) 11beta-hsd1-inhibitoren
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
ATE503755T1 (de) Cgrp-rezeptorantagonisten
ATE466860T1 (de) Cgrp-rezeptorantagonisten
MX2009010083A (es) Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro.
SE0403171D0 (sv) New compounds
ATE517861T1 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
PE20070619A1 (es) TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA
MY157116A (en) Novel seh inhibitors and their use
SE0301446D0 (sv) New Compounds
EA200501595A1 (ru) Азабициклические производные в качестве антагонистов мускаринового рецептора
ATE466853T1 (de) Cgrp-rezeptorantagonisten

Legal Events

Date Code Title Description
FD Application declared void or lapsed